FDA Inspection 1136122 — Imaging Endpoints II, LLC
The FDA completed an inspection of Imaging Endpoints II, LLC on February 12, 2021 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 12, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scottsdale, AZ (United States)
Additional Details
Sponsor, Contract Research Organization